Abstract:<h3>Background</h3><p>Eukaryotic Initiation Factor 4E-Binding Protein (<em>EIF4EBP1</em>, 4EBP1) is overexpressed in many human cancers including breast cancer, yet the role of 4EBP1 in breast cancer remains understudied. Despite the known role of 4EBP1 as a negative regulator of cap-dependent protein translation, 4EBP1 is predicted to be an essential driving oncogene in many cancer cell lines in vitro, and can act as a driver of cancer cell proliferation. <em>EIF4EBP1</em> is located within the 8p11-p12 genomic locus, which is frequently amplified in breast cancer and is known to predict poor prognosis and resistance to endocrine therapy.</p><h3>Methods</h3><p>Here we evaluated the effect of 4EBP1 targeting using shRNA knock-down of expression of 4EBP1, as well as response to the mTORC targeted drug everolimus in cell lines representing different breast cancer subtypes, including breast cancer cells with the 8p11-p12 amplicon, to better define a context and mechanism for oncogenic 4EBP1.</p><h3>Results</h3><p>Using a genome-scale shRNA screen on the SUM panel of breast cancer cell lines, we found 4EBP1 to be a strong hit in the 8p11 amplified SUM-44 cells, which have amplification and overexpression of 4EBP1. We then found that knock-down of 4EBP1 resulted in dramatic reductions in cell proliferation in 8p11 amplified breast cancer cells as well as in other luminal breast cancer cell lines, but had little or no effect on the proliferation of immortalized but non-tumorigenic human mammary epithelial cells. Kaplan-Meier analysis of <em>EIF4EBP1</em> expression in breast cancer patients demonstrated that overexpression of this gene was associated with reduced relapse free patient survival across all breast tumor subtypes.</p><h3>Conclusions</h3><p>These results are consistent with an oncogenic role of 4EBP1 in luminal breast cancer and suggests a role for this protein in cell proliferation distinct from its more well-known role as a regulator of cap-dependent translation.</p>

Eukaryotic initiation factor 4B is a multi-functional RNA binding protein that regulates histone mRNAs

Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers

The eukaryotic translation initiation factor eIF4E reprograms alternative splicing

Elevated Nuclear Phospho-Eif4e Body Levels Are Associated with Tumor Progression and Poor Prognosis for Acute Myeloid Leukemia

Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers

[Role of Eukaryotic Translation Initiation Factor 4G in Tumor].

The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled

Eif4e Binding Protein 1 Expression is Associated with Clinical Survival Outcomes in Colorectal Cancer

Eukaryotic Translation Initiation Factors and Tumor

Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation.

Critical and differential roles of eIF4A1 and eIF4A2 in B-cell development and function

4E-BP1, a multifactor regulated multifunctional protein

eIF4B stimulates eIF4A ATPase and unwinding activities by direct interaction through its 7-repeats region

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer

TFIIB-related factor 1 is a nucleolar protein that promotes RNA polymerase I-directed transcription and tumour cell growth

Eukaryotic Translation Initiation Factor 3 and Tumor

The Expression Of Proto-Oncogene Eif4e In Laryngeal Squamous Cell Carcinoma

Eukaryotic initiation factors eIF4F and eIF4B promote translation termination upon closed-loop formation

Dissecting Eif4e Action In Tumorigenesis

Small-Molecule Inhibitors Targeting Eif4a in Leukemia